David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medical Ethics 22 (2):105-110 (1996)
The possibility of early diagnosis and intervention is radically changed by the advent of genetic testing. The recent report of the Nuffield Council on Bioethics is timely and helpful. I have suggested, that not only the severity of the disability indicated by genetic information, and the accuracy of the data, ought to govern the approach to the implementation of screening for genetic disorders. In addition, assessment of the value of the information to those involved should be considered. The efficacy of the available therapeutic measures, combined with the prognostic data are important indices of the value of the information. These measures fall into three categories and thus indicate that three different courses of intervention may be appropriate. Three approaches to diagnosis and intervention are then outlined, drawing on the experience of various clinical initiatives
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Elisabeth Hildt (2002). Autonomy and Freedom of Choice in Prenatal Genetic Diagnosis. Medicine, Health Care and Philosophy 5 (1):65-72.
Felix Thiele (2003). Genetic Tests in the Insurance System: Criteria for a Moral Evaluation. Poiesis and Praxis 1 (3):185-195.
Marcia Riordan (2012). Maternal Serum Testing: Is Invasive Testing a Passing Era. Bioethics Research Notes 24 (1):7.
Barabara Biesecker (1998). Future Directions in Genetic Counseling: Practical and Ethical Considerations. Kennedy Institute of Ethics Journal 8 (2):145-160.
Mairi Levitt & Elisa Pieri, ‘‘‘It Could Just Be an Additional Test Couldn’T It?’:Genetic Testing for Susceptibility to Aggression and Violence.
Lisa Bortolotti & Heather Widdows (2011). The Right Not to Know: The Case of Psychiatric Disorders. Journal of Medical Ethics 37 (11):673-676.
Nancy Berlinger (2004). Genetic Testing After Breast Cancer Diagnosis: Implications for Physician-Patient Communications. Cambridge Quarterly of Healthcare Ethics 13 (4):417-419.
Nancy Green (2012). Argumentation and Risk Communication About Genetic Testing: Challenges for Healthcare Consumers and Implications for Computer Systems. Journal of Argumentation in Context 1 (1):113-129.
Chris MacDonald & Bryn Williams-Jones (2002). Ethics and Genetics: Susceptibility Testing in the Workplace. [REVIEW] Journal of Business Ethics 35 (3):235 - 241.
Niklas Mattsson, David Brax & Henrik Zetterberg (2010). To Know or Not to Know - Ethical Issues Related to Early Diagnosis of Alzheimer's Disease. International Journal of Alzheimer's Disease.
Walter Glannon (2001). Genes and Future People: Philosophical Issues in Human Genetics. Westview Press.
A. Boyce & P. Borry (2009). Parental Authority, Future Autonomy, and Assessing Risks of Predictive Genetic Testing in Minors. Journal of Bioethical Inquiry 6 (3):379-385.
Rebecca Bennett (2001). Antenatal Genetic Testing and the Right to Remain in Ignorance. Theoretical Medicine and Bioethics 22 (5):461-471.
Jyotsna Agnihotri Gupta (2007). Private and Public Eugenics: Genetic Testing and Screening in India. [REVIEW] Journal of Bioethical Inquiry 4 (3):217-228.
Added to index2010-09-13
Total downloads62 ( #68,297 of 1,796,306 )
Recent downloads (6 months)5 ( #169,168 of 1,796,306 )
How can I increase my downloads?